The clustering patterns did not correlate with the clinical information associated with the sample of origin (Table S1), the cell line phenotypes, including the status of CDKN2A, MDM2 and TP53, nor with the differentiation capacity or in vivo tumour formation capacity [21], [22]. The gene discussed is TP53; the disease is neoplasm.